...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith and Newsoara Biopharma Announce Expanded Licensing and Investment.

fouremm,,,you got that correct!!!!!,,,this team we have c/w the BoDs have no issue throwing the baby out with the bath water,,,,,,weak deals point to business failure across the spectum and certainly alive and well in Zenith also!!,,,pitiful!!,,I also see a trading issue on the US OTC market this am and ponder what ever is to become of this company!!!!....uuuggghhhhh!!!

Share
New Message
Please login to post a reply